⌘K

Login Start Free

Home/Filings/4/0001213900-22-080971

4//SEC Filing

Tegge Jonathan 4

Accession 0001213900-22-080971

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:04 PM ET

Size

5.2 KB

Accession

0001213900-22-080971

Insider Transaction Report

Form 4

Period: 2022-12-16

InMed Pharmaceuticals Inc.INM

Interim CFO

Transactions

Award
Employee Stock Option (Right to Buy)
2022-12-16+1,400→ 1,400 total
Exercise: $1.78Exp: 2027-12-15→ Common shares (1,400 underlying)

Footnotes (1)

[F1]Vesting 1/12 per month, in arrears, for 12 months.

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001755310

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 5:04 PM ET
Size: 5.2 KB

View on SEC.gov